Social Norms Shift, But U.S. Rules On Cannabis-Related Drug R&D Lag Behind
Executive Summary
While public, regulatory and law enforcement attitudes toward marijuana in the U.S. continue to shift, it’s still tough to pursue legitimate clinical research on cannabis and cannabinoids. Could the exceptions slowly become the rule?